GILD — Gilead Sciences Inc
In 2026 Q2, 11 of the 140 tracked hedge funds reported a position in Gilead Sciences Inc (GILD), worth $393.89M combined. Over the quarter 4 opened or added, 7 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $280.14M | 0.39% | +3% |
| VanEck | $90.52M | 0.06% | -40.5% |
| Keystone | $9.49M | 0.51% | -63.8% |
| Augustine | $6.13M | 1.20% | -0.9% |
| IMC | $2.93M | 0.03% | NEW |
| BOCHK | $2.50M | 0.39% | NEW |
| Quadrature | $1.73M | 0.01% | -75.9% |
| Polymer | $335.43K | 0.05% | -0.3% |
| Pingora | $63.17K | 0.04% | NO CHANGE |
| Parvin | $25.27K | 0.02% | NO CHANGE |
| Persistent | $24.51K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.